BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Dr. Werner Schafer Joins Supervisory Board Of BioVisioN AG


10/19/2005 5:11:14 PM

HANNOVER, Germany, August 6 /PRNewswire/ -- BioVisioN AG, based in Hannover, Germany, has announced a change in its Supervisory Board. Effective July 1, 2004, Dr. Werner Schafer has joined the supervisory board of BioVisioN AG, replacing Erich Mayer. Dr. Schafer, Chairman of the BRAHMS AG, Berlin, has many years of experiences in the pharmaceutical and diagnostic industry. From 1995 to 2002 he was member of the executive committee of Roche Diagnostics GmbH. Before that he was Head of Area Operations and Scientific Development of ABBOTT Diagnostics GmbH.

"We are honoured and privileged to have Dr. Schafer join our Supervisory Board", said BioVisioN's CEO Dr Sven Rohmann. "It is great for our company that he will assist us with his profound knowledge of the pharmaceutical industry. Working with him we will gain important impulses for the further development of our company."

Supervisory Board and Management of BioVisioN AG thank Erich Mayer for the excellent and close collaboration in an important period of the company.

BioVisioN AG specialises in the identification of disease-relevant peptides and proteins, using its proprietary Peptidomics(R) technologies in order to discover new diagnostic markers, biomarkers and therapeutic leads in preclinical research and as Clinical Peptidomics in studies accompanying clinical trials. BioVisioN provides access to its technology in fee-for-service contracts as a Biological Research Organisation and also within larger scale research collaborations.

BioVisioN AG Feodor-Lynen-Str. 5 30625 Hannover Tel: +49-511-538-896-0 Fax: +49-511-538-896-66 Contact: Dr. Rainer Voegeli, CBO For further information please refer to http://www.biovision-discovery.de/

BioVisioN AG

CONTACT: BioVisioN AG, Feodor-Lynen-Str. 5, 30625 Hannover, Tel:+49-511-538 896-0 Fax: +49-511-538 896-66 Contact: Dr. RainerVoegeli, CBO For further information please refer tohttp://www.biovision-discovery.de/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES